Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
Ann Pathol ; 34(1): 51-63, 2014 Feb.
Article in French | MEDLINE | ID: mdl-24630637

ABSTRACT

Mesothelioma is a rare disease less than 0.3% of cancers in France, very aggressive and resistant to the majority of conventional therapies. Asbestos exposure is nearly the only recognized cause of mesothelioma in men observed in 80% of case. In 1990, the projections based on mortality predicted a raise of incidence in mesothelioma for the next three decades. Nowadays, the diagnosis of this cancer is based on pathology, but the histological presentation frequently heterogeneous, is responsible for numerous pitfalls and major problems of early detection toward effective therapy. Facing such a diagnostic, epidemiological and medico-legal context, a national and international multidisciplinary network has been progressively set up in order to answer to epidemiological survey, translational or academic research questions. Moreover, in response to the action of the French Cancer Program (action 23.1) a network of pathologists was organized for expert pathological second opinion using a standardized procedure of certification for mesothelioma diagnosis. We describe the network organization and show the results during this last 15years period of time from 1998-2013. These results show the major impact on patient's management, and confirm the interest of this second opinion to provide accuracy of epidemiological data, quality of medico-legal acknowledgement and accuracy of clinical diagnostic for the benefit of patients. We also show the impact of these collaborative efforts for creating a high quality clinicobiological, epidemiological and therapeutic data collection for improvement of the knowledge of this dramatic disease.


Subject(s)
Mesothelioma , Pleural Neoplasms , France , Humans , Mesothelioma/pathology , Pathology, Clinical , Pleural Neoplasms/pathology , Referral and Consultation , Societies, Medical , Time Factors
2.
Thorax ; 69(6): 532-9, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24508707

ABSTRACT

OBJECTIVES: To estimate the proportion of pleural mesothelioma cases that can be attributed to asbestos exposure in France including non-occupational exposure. METHODS: A population-based case-control study including 437 incident cases and 874 controls was conducted from 1998 to 2002. Occupational and non-occupational asbestos exposure was assessed retrospectively by two expert hygienists. ORs of pleural mesothelioma for asbestos-exposed subjects compared to non-exposed subjects, and population-attributable risk (ARp) of asbestos exposure were estimated using a conditional logistic regression. RESULTS: A clear dose-response relationship was observed between occupational asbestos exposure and pleural mesothelioma (OR=4.0 (99% CI 1.9 to 8.3) for men exposed at less than 0.1 f/mL-year vs. 67.0 (99% CI 25.6 to 175.1) for men exposed at more than 10 f/mL-year). The occupational asbestos ARp was 83.1% (99% CI 74.5% to 91.7%) for men and 41.7% (99% CI 25.3% to 58.0%) for women. A higher risk of pleural mesothelioma was observed in subjects non-occupationally exposed to asbestos compared to those never exposed. The non-occupational asbestos ARp for these subjects was 20.0% (99% CI -33.5% to 73.5%) in men and 38.7% (99% CI 8.4% to 69.0%) in women. When considering all kinds of asbestos exposure, ARp was 87.3% (99% CI 78.9% to 95.7%) for men and 64.8% (99% CI 45.4% to 84.3%) for women. CONCLUSIONS: Our study suggests that the overall ARp in women is largely driven by non-occupational asbestos exposure arguing for the strong impact of such exposure in pleural mesothelioma occurrence. Considering the difficulty in assessing domestic or environmental asbestos exposure, this could explain the observed difference in ARp between men and women.


Subject(s)
Asbestos/toxicity , Lung Neoplasms/etiology , Mesothelioma/etiology , Occupational Diseases/etiology , Occupational Exposure/adverse effects , Pleural Neoplasms/etiology , Adult , Aged , Aged, 80 and over , Case-Control Studies , Environmental Exposure , Female , France/epidemiology , Humans , Lung Neoplasms/epidemiology , Male , Mesothelioma/epidemiology , Mesothelioma, Malignant , Middle Aged , Occupational Diseases/epidemiology , Odds Ratio , Pleural Neoplasms/epidemiology , Retrospective Studies , Sex Factors , Time Factors
3.
Pathol Biol (Paris) ; 58(5): 372-80, 2010 Oct.
Article in French | MEDLINE | ID: mdl-20850938

ABSTRACT

Erythropoietic protoporphyria (EPP) is an inherited disorder of heme biosynthesis that results from an accumulation of protoporphyrin IX in erythroid cells, plasma, skin and liver. EPP leads to acute photosensitivity and, in about 2% of patients, liver disease. EPP is a complex syndrome in which two genes are independently involved: FECH and ALAS2. More than 96% of unrelated EPP patients have ferrochelatase (FECH) deficiency (MIM 177000). Four percent of them present with autosomal recessive inheritance with two mutated FECH alleles. In dominant cases (95%) the inheritance of a common hypomorphic IVS3-48C FECH allele trans to a deleterious FECH mutation reduces FECH activity below a critical threshold. The frequency of the IVS3-48C allele differs widely from the Japanese (45%), to Black West Africans (<1%) populations. These differences in the frequency of this single common SNP account for the prevalence of overt EPP in different countries and for the absence of EPP in Black Africans. The phylogenic origin of the IVS3-48C haplotypes strongly suggests that the IVS3-48C allele arose from a single recent mutational event that occurred 60 Kyears ago. Acquired somatic mutation of FECH secondary to myeloid disease may also exceptionally cause EPP (<1%). Finally, about 4% of unrelated EPP patients have X-linked dominant protoporphyria (XLDPP) (MIM 300752) caused by gain-of-function mutations in the ALAS2 gene leading to an increased erythroid heme biosynthesis and subsequently an accumulation of protoporphyrin without any FECH deficiency.


Subject(s)
5-Aminolevulinate Synthetase/genetics , Ferrochelatase/genetics , Protoporphyria, Erythropoietic/genetics , Amino Acid Sequence , Female , Genes, Dominant , Genes, Recessive , Genes, X-Linked , Genetic Diseases, X-Linked/epidemiology , Genetic Diseases, X-Linked/genetics , Genotype , Humans , Male , Molecular Sequence Data , Mutation , Phenotype , Protoporphyria, Erythropoietic/epidemiology , Protoporphyria, Erythropoietic/ethnology , Racial Groups/genetics , Terminology as Topic
4.
Cell Mol Biol (Noisy-le-grand) ; 55(1): 45-52, 2009 Feb 16.
Article in English | MEDLINE | ID: mdl-19268001

ABSTRACT

Partial deficiency of the last enzyme of the heme biosynthetic pathway (namely ferrochelatase, FECH) in humans is responsible for erythropoietic protoporphyria (EPP). This disorder is characterised by painful photosensitivity, due to excessive production of protoporphyrin IX (PPIX) by erythrocytes. Controversial hypotheses have been proposed to explain the hematologic and iron status of EPP patients. In the present work, we explored these parameters in 55 patients with dominant EPP recruited at the French Center of Porphyrias (Colombes, France) and confirmed by molecular analysis. Our data show that erythrocyte accumulation of PPIX in EPP patients influences hematologic and iron status. Patients studied had a mild anemia and thrombocytopenia, as shown by the downward shift of hematologic parameters, which positively correlated with the amount of erythrocyte PPIX. Interestingly, erythropoiesis did not seem to be limited by iron supply in patients, since serum iron and soluble transferring (Tf) receptor (sTfR) were normal. However, iron and Tf saturation negatively correlated with erythrocyte PPIX. Moreover, and as previously described in a mouse model of EPP, we noted a positive correlation between erythrocyte PPIX and Tf levels. Altogether, these results suggest a positive effect of PPIX on the synthesis on Tf, which could facilitate the mobilization of tissue iron stores to meet erythropoiesis requirement. Based on these observations and previous results in EPP mouse model, we propose that the PPIX-liver transferrin pathway plays a role in the orchestration of iron distribution between peripheral iron stores, the spleen and the bone marrow.


Subject(s)
Erythrocytes/metabolism , Iron/metabolism , Protoporphyria, Erythropoietic/blood , Protoporphyria, Erythropoietic/metabolism , Protoporphyrins/metabolism , Adolescent , Adult , Child , Erythropoiesis/physiology , Female , Humans , Lipids/blood , Liver Function Tests , Male , Middle Aged , Porphyrins/metabolism , Protoporphyria, Erythropoietic/genetics , Young Adult
5.
Transfusion ; 34(9): 790-5, 1994 Sep.
Article in English | MEDLINE | ID: mdl-8091469

ABSTRACT

BACKGROUND: The results obtained in sequential specimens from recently infected subjects generally provide the best means of comparing the sensitivity of assays. STUDY DESIGN AND METHODS: The sensitivity of second- and third-generation assays for antibody to hepatitis C virus (HCV) was compared on sequential specimens, generally collected at monthly intervals from 45 patients undergoing hemodialysis who seroconverted for HCV between 1980 and 1990. RESULTS: Fifteen patients (33%) were positive earlier in the third-generation enzyme-linked immunosorbent assay (ELISA), with a mean difference of 17 days (range, 7-30) between the last negative and the first positive specimens. At the first rise in alanine aminotransferase, and at its peak, 63 and 91 percent of the patients, respectively, were anti-HCV positive in the third-generation ELISA. Third-generation recombinant immunoblot assay (RIBA) reacted at the same time as third-generation ELISA. Of the first specimens that were positive in second-generation ELISA, 44 percent reacted and 56 percent were indeterminate in third-generation RIBA, while 10 percent reacted, 72 percent were indeterminate, and 18 percent did not react in second-generation RIBA. From the beginning to the end of the follow-up, antibody to c33c was the most prevalent, followed in descending order by antibody to c22-3, antibody to c100-3, and antibody to NS5: 56, 54, 26, and 18 percent, respectively, at time 0, and 100, 86, 83, and 31 percent, respectively, 12 months later. CONCLUSION: Third-generation assays (both ELISA and RIBA) were more sensitive than second-generation assays in the diagnosis of HCV infection, in that positive results were obtained earlier and a higher proportion of specimens were confirmed positive in RIBA testing.


Subject(s)
Enzyme-Linked Immunosorbent Assay , Hepacivirus/immunology , Hepatitis Antibodies/blood , Immunoblotting , Renal Dialysis , Alanine Transaminase/blood , Humans , Time Factors
6.
Kidney Int ; 46(2): 504-11, 1994 Aug.
Article in English | MEDLINE | ID: mdl-7967364

ABSTRACT

A prospective non-A, non-B follow-up program, implemented in a hepatitis B surface antigen-free dialysis unit, enabled us to report on the natural history of hepatitis C virus (HCV) infection in hemodialyzed patients between 1980 and 1992. For this program, every patient was prospectively monitored every two weeks for alanine amino transferase (ALT) activity, and every month for gammaglutamyl transpeptidase (GGT) activity and systematic collection of frozen sera. Sequences of stored sera from 217 patients were repeatedly tested for anti-HCV antibodies using second generation assays. Eighty-six of the 217 patients (39.6%), including 61 of the 67 patients with non-A, non-B hepatitis (91%), had HCV infection repeatedly evidenced by positive ELISA in all, and confirmed by RIBA in 84 of 86 (97.5%). In addition, 19 out of 23 patients (82.6%) were positive for HCV RNA by the polymerase chain reaction (PCR). Of the 86 anti-HCV positive patients, 41 had previously acquired HCV infection, and 45 seroconverted during chronic dialysis. Of these, all but one patient developed hepatitis with raised ALT activity which lasted for at least six months in all. Only 29 of 45 patients (64.5%) had a history of blood transfusion. Seventy-eight of the 86 patients (91%) who were followed up for one to 11.5 years (median 5) retained anti-HCV for several years. Nineteen liver biopsies performed in 16 patients showed chronic active hepatitis in 8 (50%) and hepatocellular carcinoma without cirrhosis in one patient.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Hepatitis C/etiology , Renal Dialysis , Alanine Transaminase/blood , Antibodies, Viral/analysis , Cross Infection/etiology , Enzyme-Linked Immunosorbent Assay , Female , Follow-Up Studies , France/epidemiology , Hepacivirus/genetics , Hepacivirus/immunology , Hepatitis C/blood , Hepatitis C/epidemiology , Humans , Kidney Failure, Chronic/therapy , Longitudinal Studies , Male , Middle Aged , Prospective Studies , RNA, Viral/analysis , Retrospective Studies , Transfusion Reaction , gamma-Glutamyltransferase/blood
7.
Biochem Biophys Res Commun ; 195(2): 565-73, 1993 Sep 15.
Article in English | MEDLINE | ID: mdl-8373397

ABSTRACT

The structure of the TAR RNA element transcribed at the 5' end of the R region of the human immunodeficiency virus is compared to the structure of its duplicate sequence in the 3' R region of the viral genome. Based on the 5'-TAR secondary structure already described, we assessed by RNase T1 primer extension assay the degree of similarity between the 5'-TAR and the 3'-TAR RNA secondary structures. We also analysed the influence of modifications in the flanking sequences. We show that the secondary structures of the 5'-TAR and the 3'-TAR are very similar and are not influenced by the flanking sequences.


Subject(s)
HIV-1/metabolism , Nucleic Acid Conformation , RNA, Viral/chemistry , RNA-Binding Proteins/chemistry , Base Composition , Base Sequence , Genome, Viral , HIV Long Terminal Repeat , HIV-1/genetics , Models, Structural , Molecular Sequence Data , Oligodeoxyribonucleotides , Plasmids , RNA, Viral/biosynthesis , RNA-Binding Proteins/biosynthesis , Transcription, Genetic
8.
Pediatrie ; 44(3): 197-202, 1989.
Article in French | MEDLINE | ID: mdl-2740188

ABSTRACT

The authors present a computer program written in UCSD Pascal) which monitors the dietary management of children with kidney diseases. Diet is established according to height, weight, chronological and statural age and recommended dietary allowances (USRDA). The composition of the prescribed diet and of food intake is given as amounts of animal and vegetable protein, fat, carbohydrates, energy, water, Na, K, Ca, P and renal solute load, per day and per kilo BW as compared to RDA. The amount of food is presented in tabular form, per day, per meal, per feed, or per tube-feeding with the schedule. It is possible to calculate the nutrients of food recipes. The food table includes 500 items, that can be modified as required. The drug table contains 100 items. The program calculates also average food consumption for dietary surveys. Diets, recipes and food tables may be viewed and modified before print out at each step of the calculation. The diet data bank stores 100 diets per floppy disk.


Subject(s)
Kidney Diseases/diet therapy , Software , Therapy, Computer-Assisted , Child , Child, Preschool , Humans , Nutritional Requirements
SELECTION OF CITATIONS
SEARCH DETAIL
...